Alzheimeriň keselligi beýniniň öýjükleriniň bozulmagyna we ölmegine sebäp bolýan, ýatlamak ukybynyň, pikir etmegiň we pikirlenmek ukyplarynyň gowşamagyna eltýän ilerleýän nevrologik keseldir.
Bu demensiýanyň iň köp görlen sebäpidir, ähli ýagdaýlaryň 60-80%-i üçin hasaplanýar.
Bu kesel soňunda ölüm getirýär, kesel anyklanandan soň ortaça ömür garaşylýan wagty 4-8 ýyl, ýöne käbir adamlar kesel bilen 20 ýyla çenli ýaşap bilýärler.
Alzheimeriň keselinden ölüm derejesi barlagdan we barlanýan jemgyýetden tapawutlanýar.
Altsgeýmer birleşiginiň aýtmagyna görä, Altsgeýmer keselligi ABŞ-da ölümleriň altynjy esasy sebäpidir we 65 we ondan uly ýaşdaky adamlaryň ölümleriniň bäşinji esasy sebäpidir.
2019da Altsgeýmer keselligi ABŞda 121,9444 adamyň ölüminiň esasy sebäbi hökmünde habar berlipdir.
Altsgeýmer keselinden ölýänleriň sanynyň diňe keselden däl, eýsem keselden dörän agyrlaşmalar we başga saglyk meselelerinden hemdigini unutmaly däl.
Kesel ilerlänçe, her günki ýaşaýşyň işleri, meselem, iýmek, ýuwunmak we geýniş ýaly kynçylyklar bolup biler, bu näz-nygmatdan, infeksiyalardan we başga saglyk kynçylyklaryna eltmegi mümkin.
Şeýle - de Altsgeýmer keselinden ejir çekýän adamlar ýykylmak, pnevmoniýa we başga - da keselçiliklere uçramak mümkin.
Häzirki wagtda Altsgeymer keseliniň bejerişi ýok bolsa-da, keselligiň alamatlaryny bejermäge we durmuşyň kalitesini gowulandyrmaga kömek edýän bejergiler bar.
Täze bejergiler we soňunda bu heläkleýji keselden gutulyş tapmak üçin barlaglar dowam edýär.
Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.
Almeida MC, Gomes Cde M, Nascimento LF: Spatial distribution of deaths due to Alzheimer's disease in the state of São Paulo, Brazil. Sao Paulo Med J. 2014, 132 (4): 199-204.
Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998, 55 (9): 1226-32.
Breitner JC: Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991, 115 (8): 601-6.
Iulita MF, Garzón Chavez D, Klitgaard Christensen M, Valle Tamayo N, Plana-Ripoll O, Rasmussen SA, Roqué Figuls M, Alcolea D, Videla L, Barroeta I, Benejam B, Altuna M, Padilla C, Pegueroles J, Fernandez S, Belbin O, Carmona-Iragui M, Blesa R, Lleó A, Bejanin A, Fortea J: Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA Netw Open. 2022, 5 (5): e2212910.
['Ýagşylykdan ýüz öwürmek: medisina']
['Bu web - saýt diňe bilim we maglumat bermek üçin niýetlenen.']
['Berilen maglumat saglyk meselesini ýa-da keselini anyklamak ýa-da bejermek üçin ulanmaly däl we şahsy lukman maslahatyny gözleýänler lukman bilen maslahatlaşmaly.']
['Soragyň jogabyny döredýän sinir tory sanly maglumat babatda nädogry bolup biler.']
['Her wagt lukmanyňyzyň ýa-da başga bir saglyk hyzmatçysynyň maslahatyny sorap görüň. Bu web-saýtda okan zadyňyz üçin hiç haçan lukmanlaryň maslahatyny äsgermezlik etmäň ýa-da ony soramaga soňa goýmaň. Eger sizde medisina ýagdaýy kyn bolsa, 911-e jaň ediň ýa-da derrew iň golaýdaky hassahana baryň. Bu web-saýt ýa-da onuň ulanylyşy bilen lukman-hassa gatnaşygy döremeýär. BioMedLib-de, onuň işgärleri-de, ýa-da bu web-saýtda goşant goşýanlar-da, bu ýerde berilýän maglumat ýa-da onuň ulanylyşy babatda hiç hili açyk ýa-da örtülü wekilçilik etmeýärler.']
['Ýokary haklar']
['1998-nji ýylyň Digital Millennium Copyright Act, 17 U.S.C. § 512 (DMCA) haky bolanlar üçin Internetde görünýän materiallary ABŞ haky boýunça hukuklaryny bozýar diýip pikir edýänlere çäre görmäge mümkinçilik berýär. ']
['Eger siz biziň web saýtymyz ýa-da hyzmatlarymyz bilen baglanyşykly edip berilýän maglumat ýa-da materiallaryň siziň avtorlyk hukugyňyzy bozýandygyny dogry ynansaňyz, siz (ýa-da wekiliňiz) maglumat ýa-da materiallary aýyrmak ýa-da olara girmegiň bökülmegi barada bize habarlama ýollap bilersiňiz.']
['Habarlamalar elektron poçta arkaly ýazylgy ýollanmaly (elektron poçta jaýyny görmek üçin "Mugallymlar" bölüminde seret).']
['DMCA nusgasyna görä, hakyňy bozmak barada habar bermegiňde şu maglumatlar gerek: (1) hakyňy bozmakda aýyplanýan hakyňy goraýan işiň suratlandyrmasy; (2) hakyňy bozýan maglumatyň suratlandyrmasy we maglumaty tapmaga ýeterlik maglumat; (3) seniň bilen habarlaşmak üçin maglumat, şol sanda seniň adres, telefon we elektron poçtalaryň; (4) seniň hakyňy bozýan maglumatyň hak eýesi ýa-da onuň wekili tarapyndan ýa-da kanun boýunça rugsat berilmändigine gowy ynamyň bardygy barada şaýatlyk.']
['5) Siziň ýalan sözlemek jezasy astynda gol çekip, habarlamada berilýän maglumatyň dogrydigini we siziň bozulan diýip aýyplanýan avtorlyk hukugyny goramaga ygtyýaryňyzyň bardygyny tassyklaýan şaýatlygyňyz;']
['we (6) hak eýesiniň ýa-da hak eýesi adyndan hereket etmäge ygtyýary bolan adamyň fiziki ýa-da elektron goly. ']
['Eger ýokarda agzalan maglumatlaryň ählisini ýazmasaň, şikayetleriňiň çözülmegi giçleşdiriler.']
['Baglanyş']
['Haýsy soragyňyz / teklibiňiz bar bolsa bize email ýollaň.']
How deadly is alzheimer?
Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to a decline in memory, thinking, and reasoning skills.
It is the most common cause of dementia, accounting for 60-80% of all cases.
The disease is ultimately fatal, with the average life expectancy after diagnosis being 4-8 years, although some people can live up to 20 years with the disease.
The mortality rate for Alzheimer's disease varies depending on the study and the population being examined.
According to the Alzheimer's Association, Alzheimer's disease is the sixth leading cause of death in the United States, and it is the fifth leading cause of death for those aged 65 and older.
In 2019, Alzheimer's disease was reported as the underlying cause of death for 121,9444 people in the United States.
It is important to note that the mortality rate for Alzheimer's disease is not solely due to the disease itself, but also due to complications and other health issues that arise as a result of the disease.
As the disease progresses, individuals may experience difficulty with activities of daily living, such as eating, bathing, and dressing, which can lead to malnutrition, infections, and other health problems.
Additionally, individuals with Alzheimer's disease may be at an increased risk of falls, pneumonia, and other infections.
While there is currently no cure for Alzheimer's disease, there are treatments available that can help manage symptoms and improve quality of life.
Research is ongoing to develop new treatments and ultimately find a cure for this devastating disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Hakkynda']
['BioMedLib sorag-jawaplaryň döremegine avtomatlaşdyrylan kompýuterleri ulanýar (maşyn öwrenilýän algoritmler).']
['Biz PubMed/Medline-den 35 million sany biomedikal neşirleri we RefinedWeb-den web sahypalary bilen başlaýarys.']
